Skip to main content
. 2023 Aug 17;14:1217001. doi: 10.3389/fphar.2023.1217001

FIGURE 1.

FIGURE 1

Naringin has broad-spectrum anticancer pharmacological activity, which can inhibit the occurrence and development of cervical cancer, gastric cancer, prostate cancer, breast cancer, colorectal cancer, Osteosarcoma, bladder cancer cancer, ovarian cancer, Melanoma, Glioma, lung cancer, Esophageal cancer cancer, thyroid cancer, and liver cancer.